BASF ups price of EOAs in Europe

By Dan Stanton

- Last updated on GMT

BASF increases price of EOAs
BASF increases price of EOAs

Related tags Material Ethanolamine

BASF has hiked up the price of ethanolamines in Europe citing increased cost of raw materials and continuous demand.

FIne chemicals supplier BASF has upped the price of its Ethanolamines (EOAs), with monoethanolamine (MEOA), diethanolamine (DEOA) and triethanolamine (TEOA) all increasing by 55€ ($61) per metric tonne.

According to BASF spokeman Klaus-Peter Rieser, the "reason for the price increase is the consecutive increase of raw material prices and continuous demand increase."

EOAs are generated using ethylene and ammonia  and are used to make a wide range of active pharmaceutical ingredients (APIs) by drugmakers, as well as being important chemicals in other industries.

Rieser was unable to disclose which APIs comprise of EOAs, but did tell us the price hike will "apply to current supply agreements as soon as and to the extent permitted by their terms and conditions."

Fourteen months ago​, BASF pushed the price up €20/mt and over the past few years the cost of raw materials and continuous demand has driven a number of price increases for users of EOAs.

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars